Skip to main content

Meet the Analyst: Thomas Wakim & John Hester, Bell Potter Analyst

Bell Direct
December 17, 2024

Join us as we conclude our 2024 Meet the Analyst series with a bang. Our Market Analyst, Grady Wulff, sits down with Bell Potter’s analysts John Hester and Thomas Wakim for a comprehensive discussion on the healthcare sector.

From deciphering Neuren Pharmaceuticals (ASX:NEU) share price fluctuations to anticipating the news flow that will share 2025 guidance and identifying why Telix Pharmaceuticals (ASX:TLX) and Clarity Pharmaceuticals (ASX:CU6) are stocks to watch in the new year, John and Thomas cover it all in this final episode of the year.

In this video, John and Thomas discuss:

  • (1:48): the headwinds & tailwinds facing the healthcare sector
  • (7:10): why they are bullish on Neuren
  • (13:48): opportunities in healthcare stocks for 2025
  • (15:18): what’s on their clinical data radar for the upcoming year.

Morning Bell 31 March

Paulina Peters
March 31, 2022

Morning Bell 30 March

Sophia Mavridis
March 30, 2022

Morning Bell 29 March

Paulina Peters
March 29, 2022

Morning Bell 28 March

Sophia Mavridis
March 28, 2022

Weekly Wrap 25 March

Sophia Mavridis
March 25, 2022

Morning Bell 24 March

Sophia Mavridis
March 24, 2022

Morning Bell 23 March

Paulina Peters
March 23, 2022

Morning Bell 22 March

Paulina Peters
March 22, 2022

Morning Bell 21 March

Sophia Mavridis
March 21, 2022

Weekly Wrap 18 March

Sophia Mavridis
March 18, 2022

Morning Bell 17 March

Paulina Peters
March 17, 2022